Taiwan FDA registration 575e0c58f95ce7c6ad4a73415e120e19
Vitex biochemical products cannabinoid reagent group
TW: 維特司生化產品大麻素試劑組
Taiwan·Risk Class 2·ORTHO-CLINICAL DIAGNOSTICS, INC.;; ORTHO-CLINICAL DIAGNOSTICS, INC·Registered Apr 30, 2009 – Apr 30, 2029ActiveRegistration details
- Analysis ID
- 575e0c58f95ce7c6ad4a73415e120e19
- Customs Code
- DHA00601999802
Company information
- Manufacturer Country
- United States
- Authorized Representative
- DKSH TAIWAN LTD.
Product details
- Intended Use
- On the VITROS 5, 1 FS chemical analyzer, the content of cannabinoids (THC) in human urine was semi-quantitative or qualitatively determined using cut-off values of 20 ng/mL or 50 ng/mL.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.3870 Cannabis Trial Strain;; A.1150 Calibrated Products
- Import Information
- import
Dates and status
- Registration Date
- Apr 30, 2009
- Expiry Date
- Apr 30, 2029
About this record
Access comprehensive regulatory information for Vitex biochemical products cannabinoid reagent group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 575e0c58f95ce7c6ad4a73415e120e19 and manufactured by ORTHO-CLINICAL DIAGNOSTICS, INC.;; ORTHO-CLINICAL DIAGNOSTICS, INC. The authorized representative in Taiwan is DKSH TAIWAN LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices